The 2026 final version of the SwissDRG released

On November 28, 2025, the entity managing the DRG system in Switzerland, SwissDRG, published the final (billing) version of the 2026 DRG system. In total, 19 new DRGs were introduced related to the following fields: cardiovascular, endoscopy, ENT, gastrointestinal, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, orthopedics, spine, and surgical procedures.

Some examples of the newly introduced DRGs are provided below:

• B80A Other head injuries with complex intensive care treatment / IMCK > 65/59 complexity points;
• F98D Endovascular cardiac valve intervention, age > 15 years;
• H86A Diseases and disorders of the hepatobiliary system and pancreas, age < 18 years or ERCP or evaluation for liver transplantation, one occupancy day;
• I11Z Osteotomy on extremities or specific intervention for malformation;
• N25B Other interventions on uterus and adnexa except for malignant neoplasms, without complex diagnosis or diagnostic laparoscopy, age > 17 years;
• A01Z Transplantation of liver or Langerhans cells;
• W01E Polytrauma with operative procedure or halo traction.

Also, four new add-on reimbursement categories (Zusatzengelt, ZE) related to cardiovascular, neurovascular, and peripheral vascular fields were introduced. For example, ZE-2026-48.02, with a tariff of 10,870.44 CHF, triggered by the endovascular implantation of a flow diverter for aneurysms in peripheral vessels (extracranial arteries, aorta, arteries of the extremities, spine, etc.).

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.